Cidofovir

Brands

DEA Class; Rx

Common Brand Names; Vistide (DSC)

  • Antivirals, CMV

Antiviral; acyclic phosphonate nucleotide analog; structurally similar to acyclovir; not dependent upon intracellular activation
Used for the treatment of cytomegalovirus (CMV), herpes virus infections, and adenovirus infections
Associated with renal toxicity; use with probenecid and IV hydration to reduce toxicity

Indicated for the treatment of cytomegalovirus (CMV) retinitis in persons with HIV.

For secondary cytomegalovirus (CMV) disease prophylaxis† or cytomegalovirus (CMV) retinitis prophylaxis (i.e., long-term suppressive therapy) in persons living with HIV.

Hypersensitivity to cidofovir or probenecid

SCr >1.5 mg/dL, CrCl <55 mL/min, urine protein >100 mg/dL (2+ proteinuria)

Direct intraocular injection

Concomitant nephrotoxic drugs

  • Infection
  • Chills
  • Fever
  • Headache
  • Amnesia
  • Anxiety
  • Confusion
  • Seizures
  • Insomnia
  • Weakness
  • Paresthesia
  • Alopecia
  • Rash
  • Acne
  • Skin discoloration
  • Nausea
  • Vomiting
  • Diarrhea
  • Anorexia
  • Abdominal pain
  • Constipation
  • Dyspepsia
  • Gastritis
  • Thrombocytopenia
  • Neutropenia
  • Anemia
  • Amblyopia
  • Conjunctivitis
  • Ocular hypotony
  • Tubular damage
  • Proteinuria
  • Elevated creatinine

Risk of nephrotoxicity (dose-limiting)

Risk of neutropenia

Probenecid must be administered w/each dose: 2 g PO 3 hr before cidofovir, 1 g at 2 hr & 8 hr after completion of cidofovir infusion

1 L saline IV with each cidofovir infusion; 1 add’l liter if pt can tolerate

Pregnancy Category: C

Lactation: It is not known whether cidofovir is excreted in milk. It should not be administered to nursing mothers. The CDC advises HIV-infected women not to breast-feed to avoid postnatal transmission of HIV.

Adults

5 mg/kg/week IV.

Geriatric

5 mg/kg/week IV.

Adolescents

Safety and efficacy have not been established; however, doses up to 5 mg/kg/week IV have been used off-label.

Children

Safety and efficacy have not been established; however, doses up to 5 mg/kg/week IV have been used off-label.

Infants

Safety and efficacy have not been established; however, doses up to 5 mg/kg/week IV have been used off-label.

Neonates

Safety and efficacy have not been established.

Cidofovir

injectable solution

  • 75mg/mL (375mg/5mL vial); generic
Drugs Generic
Tags ,

About the Author

postblaze

You may also like these

0